Legal: DePuy aims to reverse $8.3M metal hip implant loss

April 22, 2013 by Arezu Sarvestani

Johnson & Johnson subsidiary DePuy Orthopaedics asks a California judge to stay an $8.3 million jury decision against the company while attorneys file an appeal.

legal gavel

Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary are hoping to dodge an $8.3 million judgment stemming from the company's 1st metal-on-metal hip implant complaint to go to trial.

DePuy last week asked the Los Angeles Superior Court to put a hold on the jury's decision in a trial brought by patient Loren Kransky, who claimed his ASR hip failed less than 5 years after he received it.

In March the California jury ruled against J&J and DePuy, finding that the company's ASR XL metal-on-metal hip implant was defectively designed. The jury ruled that the companies were negligent and ordered J&J to pay $8.3 million in damages.

Sign up to get our free newsletters delivered right to your inbox.

DePuy asked the court for a stay on the final judgment to allow the company to file an appeal without bond. The company had issued a statement following the March jury decision, promising to file the appeal.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp